BGB-8035
Product Specifications
CAS Number
2283349-24-4
Target
BTK, EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.9674
Bioactivity
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
Smiles
C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4
Molecular Formula
C24H31N5O4
Molecular Weight
453.53
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SIPL664Hu01-01 10 µg
Recombinant AXL Receptor Tyrosine Kinase (AXL)
Sign In for Pricing
View Details SIPL664Hu01-02 50 µg
Recombinant AXL Receptor Tyrosine Kinase (AXL)
Sign In for Pricing
View Details